Inducible, heterologous expression of human α7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line

Brain Research

Volumn 825, Issue 1-2, 1999, Pages 172-179

  Peng, Jian Hong ^a   Lucero, Linda ^a   Fryer, John ^a   Herl, Jennifer ^a   Leonard, Sherry S ^b   Lukas, Ronald J ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Acetylcholine; Nicotine; Nicotinic acetylcholine receptor; SH EP1 cell; Tetracycline

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; ALPHA BUNGAROTOXIN; CARBACHOL; CYTOSINE; MESSENGER RNA; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; RECOMBINANT RECEPTOR; TETRACYCLINE; TUBOCURARINE CHLORIDE;

ARTICLE; CELL CLONE; CELL GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ACETYLCHOLINE; ACONITINE; ALKALOIDS; AZOCINES; BLOTTING, NORTHERN; BUNGAROTOXINS; CARBACHOL; DIMETHYLPHENYLPIPERAZINIUM IODIDE; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; INSECTICIDES; IODINE RADIOISOTOPES; NEUROBLASTOMA; NEURONS; NICOTINE; NICOTINIC AGONISTS; PLASMIDS; PROTEIN SYNTHESIS INHIBITORS; QUINOLIZINES; RECEPTORS, NICOTINIC; RECOMBINANT PROTEINS; RNA, MESSENGER; TETRACYCLINE; TRANSFECTION; TUBOCURARINE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033577455     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01066-5     Document Type: Article

References (39)

1. M. Alkondon, E.X. Albuquerque, Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: I. Pharmacological and functional evidence for distinct structural subtypes, J. Pharmacol. Exp. Ther. 265 (1993) 1455-1473.
2. M. Bencherif, K. Fowler, R.J. Lukas, P.M. Lippiello, Mechanisms of upregulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain, J. Pharmacol. Exp. Ther. 275 (1995) 987-994.
3. M. Bencherif, R.J. Lukas, Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: a possible functional role of the cytoskeleton, J. Neurochem. 61 (1993) 852-864.
4. 125I]-α-bungarotoxin binding in human postmortem brain, J. Comp. Neurol. 387 (1997) 385-398.
5. B. Buisson, M. Gopalakrishnan, S.P. Arneric, J.P. Sullivan, D. Bertrand, Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch-clamp study, J. Neurosci. 16 (1996) 7880-7891.
6. W.G. Conroy, M.S. Saedi, J. Lindstrom, TE671 cells express an abundance of a partially mature acetylcholine receptor α subunit which has characteristics of an assembly intermediate, J. Biol. Chem. 265 (1990) 21642-21651.
7. S.T. Cooper, N.S. Millar, Host cell-specific folding and assembly of the neuronal nicotinic acetylcholine receptor α7 subunit, J. Neurochem. 68 (1997) 2140-2151.
8. S. Couturier, D. Bertrand, J.M. Matter, M.C. Hernandez, S. Bertrand, N. Millar, S. Valera, T. Barkas, M. Ballivet, A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX, Neuron 5 (1990) 847-856.
9. J.N. Crawley, Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease, Life Sci. 58 (1996) 2185-2199.
10. M. Gopalakrishnan, B. Buisson, E. Touma, T. Giordano, J.E. Campbell, I.C. Hu, D. Donnelly-Roberts, S.P. Arneric, D. Bertrand, J.P. Sullivan, Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor, Eur. J. Pharmacol. 290 (1995) 237-246.
11. M. Gossen, H. Bujard, Tight control of gene expression in mammalian cells by tetracycline-responsive promoters, Proc. Natl. Acad. Sci., USA 89 (1992) 5547-5551.
12. J.A. Gray, S.N. Mitchell, M.H. Joseph, G.A. Grogoryan, S. Dawe, H. Hodges, Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine, Drug Dev. Res. 31 (1994) 3-17.
13. A. Hoffmann, M. Villalba, L. Journot, D. Spengler, A novel tetracycline-dependent expression vector with low basal expression and potent regulatory properties in various mammalian cell lines, Nucl. Acids Res. 25 (1997) 1078-1079.
14. C. Hop, V. de Waard, J.A. van Mourik, H. Pannekoek, Lack of gradual regulation of tetracycline-controlled gene expression by the tetracyclin-repressor/VP16 transactivator (tTA) in cultured cells, FEBS Lett. 405 (1997) 167-171.
15. J.R. Howe, B.V. Skryabin, S.M. Belcher, C.A. Zerillo, C. Schmauss, The responsiveness of a tetracycline-sensitive expression system differs in different cell lines, J. Biol. Chem. 270 (1995) 14168-14174.
16. L. Ke, C.M. Eisenhour, M. Bencherif, R.J. Lukas, Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes: I. Dose- and time-dependent effects of nicotine treatment, J. Pharmacol. Exp. Ther. 286 (1998) 825-840.
17. Z. Lang, J.M. Feingold, An autonomously replicating eukaryotic expression vector with a tetracycline-responsive promoter, Gene 168 (1996) 169-171.
18. K.W. Lange, F.R. Wells, P. Senner, C.D. Marsden, Altered muscarinic and nicotinic receptor densities in cortical and subcortical regions in Parkinson's disease, J. Neurochem. 60 (1993) 197-203.
19. A.D. Lawrence, B.J. Sahakian, Alzheimer disease, attention, and the cholinergic system, Alzheimer Dis. Assoc. Disord. 9 (1995) 43-49, Suppl. 2.
20. S. Leonard, C. Adams, C.R. Breese, L.E. Adler, P. Bickford, W. Byerley, H. Coon, J.M. Griffith, C. Miller, M. Myles-Worsley, H.T. Nagamoto, Y. Rollins, K.E. Stevens, M. Waldo, R. Freedman, Nicotinic receptor function in schizophrenia, Schizophr. Bull. 22 (1996) 431-445.
21. E.D. Levin, C.K. Conners, E. Sparrow, S. Hinton, W. Meck, J.E. Rose, D. Ernhardt, J. March, Nicotine effects on adults with attention deficit/hyperactivity disorder, Psychopharmacology 123 (1996) 55-63.
22. J. Lindstrom, Neuronal nicotinic acetylcholine receptors, in: T. Narahashi (Ed.), Ion Channels, Vol. 4, Plenum, New York, 1996, pp. 377-450.
23. R.J. Lukas, Properties of curaremimetic neurotoxin binding sites in the rat central nervous system, Biochemistry 23 (1984) 1152-1160.
24. R.J. Lukas, Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671, J. Neurochem. 46 (1986) 1936-1941.
25. R.J. Lukas, Diversity and patterns of regulation of nicotinic receptor subtypes, Ann. New York Acad. Sci. 757 (1995) 153-168.
26. R.J. Lukas, Neuronal nicotinic acetylcholine receptors, in: F.J. Barrantes (Ed.), The Nicotinic Acetylcholine Receptor: Current Views and Future Trends, Springer Verlag, Berlin/Heidelberg and Landes Publishing, Georgetown, TX, 1998, pp. 145-173,.
27. R.J. Lukas, L. Ke, M. Bencherif, C.M. Eisenhour, Regulation by nicotine of its own receptors, Drug Dev. Res. 38 (1996) 136-148.
28. R.J. Lukas, L. Lucero, C.M. Eisenhour, E. Puchacz, Function of transgenic nicotinic acetylcholine receptors expressed in human cells stably transfected with α7 subunits, Soc. Neurosci. Abst. 22 (1996) 1268.
29. R.J. Lukas, S.A. Norman, L. Lucero, Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line, Mol. Cell. Neurosci. 4 (1993) 1-12.
30. C.F. Newland, D. Beeson, A. Vincent, J. Newsom-Davis, Functional and non-functional isoforms of the human muscle acetylcholine receptor, J. Physiol. 489 (1995) 767-778.
31. X. Peng, V. Gerzanich, R. Anand, F. Wang, J. Lindstrom, Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y, Mol. Pharmacol. 51 (1997) 776-784.
32. J. Poirier, I. Aubert, P. Bertrand, R. Quirion, S. Gauthier, J. Nalbantoglu, Apolipoprotein E4 and cholinergic dysfunction in AD, in: E. Giacobini, R. Becker (Eds.), Alzheimer's Disease: Therapeutic Strategies, Birkhauser, Boston, 1994, pp. 72-76.
33. E. Puchacz, B. Buisson, D. Bertrand, R.J. Lukas, Functional expression of nicotinic acetylcholine receptors containing rat α7 subunits in human SH-SY5Y neuroblastoma cells, FEBS Lett. 354 (1994) 155-159.
34. E. Puchacz, J.-L. Galzi, B. Buisson, D. Bertrand, J.-P. Changeux, R.J. Lukas, Properties of transgenic nicotinic acetylcholine receptors stably expressed in human cells as homooligomers of wild-type or mutant rat or chick α7 subunits, Soc. Neurosci. Abst. 21 (1995) 1335.
35. M. Quik, J. Choremis, J. Komourian, R.J. Lukas, E. Puchacz, Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites, J. Neurochem. 67 (1996) 145-154.
36. R.A. Ross, B.A. Spengler, J.L. Biedler, Coordinate morphological and biochemical interconversion of human neuroblastoma cells, J. Natl. Cancer Inst. 71 (1983) 741-749.
37. S.B. Sands, A.C. Costa, J.W. Patrick, Barium permeability of neuronal nicotinic receptor alpha 7 expressed in Xenopus oocytes, Biophys. J. 65 (1993) 2614-2621.
38. P. Shockett, M. Difilippantonio, N. Hellman, D.G. Schatz, A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice, Proc. Natl. Acad. Sci., USA 92 (1995) 6522-6526.
39. C. Vidal, Nicotinic receptors in the brain. Molecular biology, function, and therapeutics, Mol. Chem. Neuropath. 28 (1996) 3-11.